Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
Our observations suggest that the combination therapy with baricitinib and NB-UVB is a promising strategy against NSV. Patients tolerated the treatment well without serious AEs, these results expand treatment options for vitiligo patients, warranting larger clinical trials.
Authors
- Qiang Li (ORCID: https://orcid.org/0000-0002-9059-9293)
- Zhimin Li (ORCID: https://orcid.org/0000-0001-7036-9282)
- Tao Wang (ORCID: https://orcid.org/0000-0002-0765-2226)
- Yue Zhang (ORCID: https://orcid.org/0000-0001-9461-6233)
- Jiangwen Gui (ORCID: https://orcid.org/0009-0001-8956-0324)
- Bin Zhou (ORCID: https://orcid.org/0009-0008-0703-2239)
- Wenzhi Hu
Institutions
- Hebei North University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Air Force Engineering University (CN)
- Air Force General Hospital PLA (CN)
Publication Details
- Journal
- Clinical Cosmetic and Investigational Dermatology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ccid.s501688
- Citations
- 3
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.98